Morniflumate

Major

Morniflumate Fondaparinux Injection Arixtra An increased risk of bleeding Details Morniflumate Furosemide Injection Disal Reduced diuretic effectiveness and possible nephrotoxicity Details Morniflumate Heparin An increased risk of bleeding Details Morniflumate Heparin Injection Lipo-Hepin® An increased risk of bleeding Details Morniflumate Hydrocortisone Ala-Cort Increased risk of gastrointestinal ulcer or bleeding Details Morniflumate Hydrocortisone Injection A-Hydrocort® Increased risk of gastrointestinal ulcer or bleeding Details Morniflumate Ibuprofen Addaprin An increased risk of gastrointestinal toxicity Details Morniflumate Iloprost Aurlumyn An increased risk of bleeding Details Morniflumate Ketoprofen Actron® Increased risk of bleeding Details Morniflumate Lithium Carbonate Lithobid Increased lithium exposure and an increased risk of lithium toxicity Details Morniflumate Meclofenamate Meclodium® Increased risk of bleeding Details Morniflumate Mefenamic Acid Ponstel® Increased risk of bleeding Details Morniflumate Meloxicam Alloxate An increased risk of gastrointestinal toxicity and an increased risk of bleeding Details Morniflumate Meloxicam Injection Alloxate An increased risk of gastrointestinal toxicity and an increased risk of bleeding Details Morniflumate Melphalan Alkeran An increased risk of bleeding Details Morniflumate Melphalan Injection Alkeran An increased risk of bleeding Details Morniflumate Mesalamine Apriso Increased risk of bleeding Details Morniflumate Mesalamine Rectal Canasa Increased risk of bleeding Details Morniflumate Methotrexate Jylamvo Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active metabolite for... Details Morniflumate Methotrexate Injection Abitrexate® Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active metabolite for... Details Morniflumate Nabumetone Relafen Increased risk of bleeding Details Morniflumate Naproxen Aleve Increased risk of bleeding Details Morniflumate Pemetrexed Injection Alimta Increased PEMEtrexed exposure and an increased risk of PEMEtrexed toxicity (myelosuppression, renal toxicity, and gastrointestinal... Details

Moderate

Morniflumate Lisinopril Prinivil Explained Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Morniflumate Atenolol Tenormin Explained Reduced antihypertensive effect Details Morniflumate Acebutolol Sectral® Reduced antihypertensive effect Details Morniflumate Benazepril Lotensin Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Morniflumate Azilsartan Edarbi Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Morniflumate Betaxolol Betoptic S Reduced antihypertensive effect Details Morniflumate Betaxolol Ophthalmic Betoptic® Reduced antihypertensive effect Details Morniflumate Bisoprolol Zebeta® Reduced antihypertensive effect Details Morniflumate Captopril Capoten® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Morniflumate Desmopressin Nasal Concentraid® Increased risk of water intoxication with hyponatremia Details Morniflumate Enalapril Epaned Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Morniflumate Eprosartan Teveten® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Morniflumate Esmolol Brevibloc Reduced antihypertensive effect Details Morniflumate Fosinopril Monopril® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Morniflumate Irbesartan Avapro Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Morniflumate Labetalol Normodyne® Reduced antihypertensive effect Details Morniflumate Levobunolol Ophthalmic AKBeta® Reduced antihypertensive effect Details